Quarterly report pursuant to Section 13 or 15(d)

BASIS OF PRESENTATION (Details Narrative)

v3.21.2
BASIS OF PRESENTATION (Details Narrative)
Jul. 17, 2019
shares
Emmaus Life Sciences, Inc. [Member]  
Variable Interest Entity [Line Items]  
Reverse stock split 1-for-6
Reverse stock split, conversion ratio 0.167
Telemynd [Member]  
Variable Interest Entity [Line Items]  
Common stock shares, Stock split ratio 1